Mar 21, 2026 by Seena HassounaBristow Group's CFO Just Sold $1.2 Million in Stock — But Is That the Whole Equation?Bristow Group, a global aviation services provider to offshore energy firms, reported a notable insider sale in its latest SEC filing.
Mar 21, 2026 by Seena HassounaENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to WatchThis clinical-stage biotech develops immunology therapies for autoimmune and inflammatory diseases, with a diverse pipeline underway.
Mar 20, 2026 by Seena HassounaOaktree Knows Distressed Debt. Its Garrett Motion Sale Tells You Something.Garrett Motion designs turbochargers and electric-boosting systems for global automotive manufacturers and aftermarket distributors.
Mar 19, 2026 by Seena HassounaNextech Trims Kymera at a Recent High — think Foolishly before acting.Kymera Therapeutics develops targeted protein degradation therapies for immunology and oncology, advancing a diversified clinical pipeline.
Mar 18, 2026 by Seena HassounaSignal or Noise: What VR Adviser's Spyre Theraputics Buy MeansSpyre Therapeutics focuses on antibody therapies for inflammatory bowel disease, advancing a pipeline aimed at gastrointestinal health.
Mar 18, 2026 by Seena HassounaAtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching?This medical device innovator for cardiac surgery reported a notable insider sale amid a year of negative total returns.
Mar 18, 2026 by Seena HassounaWhat to Make of VR Adviser's Big Ocular Therapeutix Sell-DownThis ophthalmic biopharma firm develops sustained drug delivery therapies for eye diseases, targeting both U.S. and global markets.
Mar 17, 2026 by Seena HassounaWhat's Behind Naspers's Steady Exit From Remitly?Remitly, a global digital remittance provider, saw significant insider selling as disclosed in recent regulatory filings.
Mar 15, 2026 by Seena HassounaISCG vs. RZG: Which Small-Cap Growth ETF Fits Your Portfolio?Expense ratios, sector tilts, and portfolio breadth set these two small-cap growth ETFs apart for investors weighing their options.
Mar 15, 2026 by Seena HassounaCBIZ Insider Sale: Trust Move or Warning Sign?CBIZ, Inc., a major business services provider, reported significant insider selling amid a year of sharp share price declines.
Mar 15, 2026 by Seena HassounaA Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you?This clinical-stage biotech develops antibody therapies targeting autoimmune diseases, with a lead candidate in Phase II trials.
Mar 13, 2026 by Seena HassounaA Hedge Fund Just Trimmed $2.7 Million of NCR Voyix. Should You Care?NCR Voyix delivers technology and managed services across retail, hospitality, and financial services for enterprise clients worldwide.
